No Prescription » Prescription Drugs 15 » Temonat Temodal
This medication is used to treat certain types of brain cancer. It is a chemotherapy drug that works by slowing cancer cell growth. In some patients temozolomide decreases the size of brain tumors.How to use Temozolomide OralRead the Patient Information Leaflet provided by your pharmacist before you start using temozolomide and each time you get a refill. If you have any questions about the information or if you are not certain which days of the treatment cycle to take your medication consult your doctor or pharmacist.Take this medication by mouth usually once daily or as directed by your doctor. To reduce nausea and vomiting take it on an empty stomach (1 hour before or 3 hours after a meal) or at bedtime unless otherwise directed by your doctor. To make sure the amount of medicine in your body is kept at a constant level take it at the same time every day in relation to a meal (e.g. always 1 hour before the evening meal or always 3 hours after the evening meal).Swallow the capsules whole with a full glass of water (8 ounces or 240 milliliters). The dosage is based on your medical condition body size and response to therapy.Do not crush chew or open the capsules. If the capsules are accidentally opened or damaged avoid inhaling the medication and do not let it touch the skin or mucous membranes (e.g. inside the nose). If contact occurs flush the area with water. Since this drug can be absorbed through the skin women who are pregnant or who may become pregnant should not handle this medication.Do not increase your dose or take this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased.What conditions does this medication treat?Temozolomide Oral is used to treat the following:A Type of Brain Cancer - Anaplastic Astrocytoma Malignant Brain Tumor Glioblastoma
Buy Temonat Temodal and other Prescription Drugs 15 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Temonat Temodal:
Product Type: Prescription Drugs 15
Temonat ( Temodal Generic Temozolomide )
Temonat (Temodal Generic Temozolomide)
Temodal Generic Temozolomide
100mg
Temodal Generic Temozolomide Temonat

View more
Prescription Drugs 15
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|